Ameriprise’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Sell |
73,380
-1,544
| -2% | -$30.6K | ﹤0.01% | 3176 |
|
|
2025
Q4 | $1.47M | Sell |
74,924
-25,805
| -26% | -$535K | ﹤0.01% | 3159 |
|
|
2025
Q3 | $2.78M | Sell |
100,729
-49,361
| -33% | -$1.52M | ﹤0.01% | 2819 |
|
|
2025
Q2 | $4.58M | Buy |
150,090
+58,921
| +65% | +$1.67M | ﹤0.01% | 2432 |
|
|
2025
Q1 | $2.46M | Buy |
91,169
+14,593
| +19% | +$462K | ﹤0.01% | 2790 |
|
|
2024
Q4 | $2.75M | Sell |
76,576
-17,051
| -18% | -$638K | ﹤0.01% | 2739 |
|
|
2024
Q3 | $3.55M | Buy |
93,627
+53,602
| +134% | +$2.2M | ﹤0.01% | 2594 |
|
|
2024
Q2 | $1.81M | Sell |
40,025
-2,151
| -5% | -$99K | ﹤0.01% | 2910 |
|
|
2024
Q1 | $2.05M | Sell |
42,176
-14,367
| -25% | -$704K | ﹤0.01% | 2862 |
|
|
2023
Q4 | $3.03M | Sell |
56,543
-256
| -0.5% | -$12.9K | ﹤0.01% | 2664 |
|
|
2023
Q3 | $3.33M | Sell |
56,799
-4,290
| -7% | -$268K | ﹤0.01% | 2574 |
|
|
2023
Q2 | $3.85M | Sell |
61,089
-9,736
| -14% | -$620K | ﹤0.01% | 2533 |
|
|
2023
Q1 | $4.45M | Buy |
70,825
+3,405
| +5% | +$203K | ﹤0.01% | 2402 |
|
|
2022
Q4 | $3.59M | Buy |
67,420
+3,259
| +5% | +$177K | ﹤0.01% | 2509 |
|
|
2022
Q3 | $3.6M | Sell |
64,161
-7,112
| -10% | -$470K | ﹤0.01% | 2457 |
|
|
2022
Q2 | $5.16M | Buy |
71,273
+6,349
| +10% | +$473K | ﹤0.01% | 2253 |
|
|
2022
Q1 | $5.16M | Buy |
64,924
+3,191
| +5% | +$288K | ﹤0.01% | 2404 |
|
|
2021
Q4 | $6.25M | Sell |
61,733
-2,703
| -4% | -$270K | ﹤0.01% | 2311 |
|
|
2021
Q3 | $5.94M | Buy |
64,436
+2,728
| +4% | +$262K | ﹤0.01% | 2266 |
|
|
2021
Q2 | $6.32M | Sell |
61,708
-2,673
| -4% | -$268K | ﹤0.01% | 2285 |
|
|
2021
Q1 | $6.28M | Sell |
64,381
-690
| -1% | -$62.8K | ﹤0.01% | 2245 |
|
|
2020
Q4 | $5.02M | Sell |
65,071
-922
| -1% | -$71.3K | ﹤0.01% | 2274 |
|
|
2020
Q3 | $4.86M | Sell |
65,993
-11,515
| -15% | -$924K | ﹤0.01% | 2108 |
|
|
2020
Q2 | $5.69M | Sell |
77,508
-22,190
| -22% | -$1.74M | ﹤0.01% | 1976 |
|
|
2020
Q1 | $5.76M | Sell |
99,698
-8,432
| -8% | -$586K | ﹤0.01% | 1812 |
|
|
2019
Q4 | $8.49M | Sell |
108,130
-3,552
| -3% | -$262K | ﹤0.01% | 1876 |
|
|
2019
Q3 | $7.64M | Buy |
111,682
+44,017
| +65% | +$2.96M | ﹤0.01% | 1902 |
|
|
2019
Q2 | $5.38M | Buy |
67,665
+19,716
| +41% | +$1.56M | ﹤0.01% | 2214 |
|
|
2019
Q1 | $4.02M | Sell |
47,949
-473
| -1% | -$49.4K | ﹤0.01% | 2362 |
|
|
2018
Q4 | $5.7M | Sell |
48,422
-4,376
| -8% | -$506K | ﹤0.01% | 2036 |
|
|
2018
Q3 | $6.36M | Sell |
52,798
-3,876
| -7% | -$481K | ﹤0.01% | 2186 |
|
|
2018
Q2 | $6.54M | Buy |
56,674
+13,634
| +32% | +$1.49M | ﹤0.01% | 2051 |
|
|
2018
Q1 | $3.7M | Sell |
43,040
-1,600
| -4% | -$124K | ﹤0.01% | 2386 |
|
|
2017
Q4 | $3.31M | Sell |
44,640
-1,288
| -3% | -$86.2K | ﹤0.01% | 2392 |
|
|
2017
Q3 | $2.65M | Sell |
45,928
-1,300
| -3% | -$76.8K | ﹤0.01% | 2462 |
|
|
2017
Q2 | $3.03M | Buy |
47,228
+2,665
| +6% | +$164K | ﹤0.01% | 2397 |
|
|
2017
Q1 | $2.57M | Buy |
44,563
+7,305
| +20% | +$436K | ﹤0.01% | 2463 |
|
|
2016
Q4 | $2.28M | Sell |
37,258
-1,418
| -4% | -$92.4K | ﹤0.01% | 2561 |
|
|
2016
Q3 | $2.68M | Sell |
38,676
-18,758
| -33% | -$1.24M | ﹤0.01% | 2412 |
|
|
2016
Q2 | $3.2M | Sell |
57,434
-60,538
| -51% | -$3.65M | ﹤0.01% | 2258 |
|
|
2016
Q1 | $7.16M | Buy |
117,972
+26,642
| +29% | +$1.57M | ﹤0.01% | 1700 |
|
|
2015
Q4 | $5.83M | Sell |
91,330
-12,834
| -12% | -$832K | ﹤0.01% | 1900 |
|
|
2015
Q3 | $6.98M | Buy |
104,164
+25,720
| +33% | +$1.82M | ﹤0.01% | 1752 |
|
|
2015
Q2 | $5.36M | Buy |
78,444
+69,170
| +746% | +$4.39M | ﹤0.01% | 2101 |
|
|
2015
Q1 | $514K | Sell |
9,274
-796
| -8% | -$40.8K | ﹤0.01% | 3193 |
|
|
2014
Q4 | $517K | Sell |
10,070
-8,550
| -46% | -$420K | ﹤0.01% | 3105 |
|
|
2014
Q3 | $685K | Buy |
18,620
+3,750
| +25% | +$135K | ﹤0.01% | 2941 |
|
|
2014
Q2 | $581K | Sell |
14,870
-7,600
| -34% | -$282K | ﹤0.01% | 2947 |
|
|
2014
Q1 | $847K | Buy |
22,470
+3,260
| +17% | +$114K | ﹤0.01% | 2788 |
|
|
2013
Q4 | $726K | Sell |
19,210
-3,708
| -16% | -$142K | ﹤0.01% | 2749 |
|
|
2013
Q3 | $994K | Sell |
22,918
-1,280
| -5% | -$51.4K | ﹤0.01% | 2688 |
|
|
2013
Q2 | $876K | Buy |
+24,198
| New | +$735K | ﹤0.01% | 2657 |
|
Other funds holding USNA
NCM
VCM
VPM
Ameriprise's USNA Position: Q1 2026 in Review
Ameriprise reduced its Usana Health Sciences (USNA) stake by 2.1% in Q1 2026, selling an estimated $30.6K and leaving 73,380 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3176.
Ameriprise first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.49M in Q4 2019. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- Ameriprise held 73,380 shares of Usana Health Sciences worth $1.28M as of Q1 2026.
- Ameriprise sold 1,544 Usana Health Sciences shares in Q1 2026, an estimated $30.6K.
- Usana Health Sciences made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3176 holding.
- Ameriprise first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Usana Health Sciences position peaked at $8.49M in Q4 2019.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.